Gamida Cell - Cord Blood Transplant

Press Releases - 2010

The Gamida Cell-TEVA Joint Venture Receives FDA Fast Track Designation for StemEx® for Leukemia and Lymphoma
Jun. 21, 2010

Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx®, a Cord Blood Stem Cell Product, for Leukemia and Lymphoma
Feb. 10, 2010

European Medicines Agency (EMA) Waives Requirement to Test StemEx® in Paediatric Patients 17 Years of Age and Under
Jan. 18, 2010

Press Releases Archive

Recent
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003

To learn more about our products and clinical trials, please fill in:
Name: 
Email: 
Country: 
* Message: